Summary

Israel diagnostic labs market is bound to experience impressive growth with anticipated CAGR in the forecast period, 2023-2027, on the account of increasing patient burden over hospitals. Increasing demand for the early diagnosis for the widespread infectious diseases, and chronic diseases is further driving the growth of the Israel diagnostic labs market in the upcoming five years. Rapidly increasing demand for the quick response during emergency situations for diagnosis are driving the growth of the Israel diagnostic labs market in the next five years.
Increasing Disease Burden Drive Market Growth
High prevalence of communicable, non-communicable, tropical, and chronic diseases is rapidly increasing and surging the demand for the early diagnosis of these diseases in the population, thus driving the growth of the Israel diagnostic labs market in the upcoming five years. Higher instances of chronic diseases like cardiovascular disease, stroke, cancer, diabetes, obesity, and arthritis are majorly driving the demands for the early diagnosis of the diseases thus supporting the growth of the Israel diagnostic labs market in the next five years.
Excessive number of patient count in Israel is being led by lifestyle issues, unhealthy food habits and communicable diseases. Factors like long working hours, unhealthy food habits, along with lack of physical activities, are responsible for the increasing cases of lifestyle diseases like diabetes, obesity, hypertension etc. the rapid increase of these diseases is anticipated to further substantiate the growth of the Israel diagnostic labs market in the future five years.
Expanding Healthcare Infrastructure Support Market Growth
Healthcare infrastructure is expanding in the country in recent years. Government aided fundings, private investments through foreign bodies or global giants penetrating the market is further anticipated to drive the growth of the Israel diagnostic labs market in the future five years. Moreover, to provide for the best healthcare services, number of diagnostic labs are increasing rapidly. Also, favorable schemes from the Israel government toward development, medical device incorporations, and establishing pharmaceutical industry along with the construction of diagnostic labs are serving up for the patient care and substantiating the growth of the Israel diagnostic labs market in the future five years.
COVID-19 Aided Diagnostic Labs Demands
In the recent wake of the pandemic, the number of patient being affected by the coronavirus infection skyrocketed all around the world. To diagnose the infection in its early stage such that timely treatment could be provided and help the patients, further upsurged the growth of the Israel diagnostic labs market in the next five years. Furthermore, demands from the geriatric population, and from the patient already seeking treatment due to chronic diseases is anticipated to facilitate the growth of the Israel diagnostic labs market in the future five years. Such patients are at a higher risk of infection and to isolate such patients in a secure environment to avoid further infection, early diagnosis and effective procedure for a systematic analysis of the population demanded diagnostic labs.
Also, increased focus on the innovative equipment and advanced labs is also anticipated to substantiate the growth of the Israel diagnostic labs market in the future five years. Additionally, increased demand for the diagnostic tests like routine blood and urine tests, high-end genetic analysis, fluorescence in situ hybridization, molecular expression testing, etc. are also aiding the growth of the Israel diagnostic labs market in the forecast years, until 2026.
Market Segmentation
The Israel diagnostic labs market segmentation is based on provider type, test type, end user, competitional landscape, and regional distribution. Based on provider type, the market is further bifurcated into hospital, stand-alone center, and diagnostic chains. Test type segment is further fragmented into radiology, and pathology. On the basis of end user, the market segments are defined as corporate clients, walk-ins, and referrals. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among the Mediterranean coastal plain, the central hills, the Jordan rift valley, the Negev desert.
Company Profile
American Medical Laboratories (AML), Scopio Labs, Assuta Medical Center, Sourasky Medical Center, Sheba Medical Center (Mega Lab), Patho-Lab Diagnostics Ltd., Savyon Diagnostics, among others is a partial list of major market players of the companies responsible for the growth of Israel diagnostic labs market.
Report Scope:
In this report, Israel diagnostic labs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Israel Diagnostic Labs Market, By Provider Type:
o Hospital
o Stand-Alone Centre
o Diagnostic Chains
• Israel Diagnostic Labs Market, By Test Type:
o Radiology
o Pathology
• Israel Diagnostic Labs Market, By End User:
o Corporate Clients
o Walk-ins
o Referrals
• Israel Diagnostic Labs Market, By Region:
o The Mediterranean Coastal Plain
o The Central Hills
o The Jordan Rift Valley
o The Negev Desert
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Israel diagnostic labs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents